176 related articles for article (PubMed ID: 28457921)
1. Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation.
Budding K; Rossato M; van de Graaf EA; Kwakkel-van Erp JM; Radstake TRDJ; Otten HG
Transpl Immunol; 2017 Jun; 42():1-4. PubMed ID: 28457921
[TBL] [Abstract][Full Text] [Related]
2. Role of Circulating MicroRNAs in the Immunopathogenesis of Rejection After Pediatric Lung Transplantation.
Xu Z; Yang W; Steward N; Sweet SC; Danziger-Isakov L; Heeger PS; Mohanakumar T
Transplantation; 2017 Oct; 101(10):2461-2468. PubMed ID: 27941431
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.
Budding K; van de Graaf EA; Kardol-Hoefnagel T; Kwakkel-van Erp JM; Luijk BD; Oudijk ED; van Kessel DA; Grutters JC; Hack CE; Otten HG
Sci Rep; 2016 May; 6():26274. PubMed ID: 27215188
[TBL] [Abstract][Full Text] [Related]
4. High circulating CD4
Durand M; Lacoste P; Danger R; Jacquemont L; Brosseau C; Durand E; Tilly G; Loy J; Foureau A; Royer PJ; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Degauque N; Magnan A; Brouard S;
J Heart Lung Transplant; 2018 Jun; 37(6):770-781. PubMed ID: 29571601
[TBL] [Abstract][Full Text] [Related]
5. YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome.
Kastelijn EA; van Moorsel CH; Ruven HJ; Korthagen NM; Kwakkel-van Erp JM; van de Graaf EA; Zanen P; van Kessel DA; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Mar; 30(1):28-35. PubMed ID: 24003532
[TBL] [Abstract][Full Text] [Related]
6. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.
Xu Z; Ramachandran S; Gunasekaran M; Zhou F; Trulock E; Kreisel D; Hachem R; Mohanakumar T
J Heart Lung Transplant; 2015 Sep; 34(9):1154-62. PubMed ID: 25979625
[TBL] [Abstract][Full Text] [Related]
9. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.
LaPar DJ; Burdick MD; Emaminia A; Harris DA; Strieter BA; Liu L; Robbins M; Kron IL; Strieter RM; Lau CL
Ann Thorac Surg; 2011 Aug; 92(2):470-7; discussion 477. PubMed ID: 21801908
[TBL] [Abstract][Full Text] [Related]
10. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
[TBL] [Abstract][Full Text] [Related]
11. Exhaled nitric oxide and carbon monoxide in lung transplanted patients.
Cameli P; Bargagli E; Fossi A; Bennett D; Voltolini L; Refini RM; Gotti G; Rottoli P
Respir Med; 2015 Sep; 109(9):1224-9. PubMed ID: 26224473
[TBL] [Abstract][Full Text] [Related]
12. Multivariate modeling using quantitative CT metrics may improve accuracy of diagnosis of bronchiolitis obliterans syndrome after lung transplantation.
Barbosa EM; Simpson S; Lee JC; Tustison N; Gee J; Shou H
Comput Biol Med; 2017 Oct; 89():275-281. PubMed ID: 28850899
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
Abedin S; Yanik GA; Braun T; Pawarode A; Magenau J; Goldstein SC; Levine JE; Kitko CL; Couriel DR
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1127-31. PubMed ID: 25687798
[TBL] [Abstract][Full Text] [Related]
14. Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation.
Budding K; van de Graaf EA; Paantjens AW; Kardol-Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Otten HG
Transpl Immunol; 2015 Jun; 32(3):195-200. PubMed ID: 25841614
[TBL] [Abstract][Full Text] [Related]
15. Lung transplantation in chronic obstructive pulmonary disease: long-term survival, freedom from bronchiolitis obliterans syndrome, and factors influencing outcome.
Zeriouh M; Mohite PN; Sabashnikov A; Zych B; Patil NP; Garcia-Saez D; Koch A; Ghodsizad A; Weymann A; Soresi S; Wittwer T; Choi YH; Wippermann J; Wahlers T; Popov AF; Simon AR
Clin Transplant; 2015 Apr; 29(4):383-92. PubMed ID: 25659973
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs.
Bozzini S; Del Fante C; Morosini M; Berezhinskiy HO; Auner S; Cattaneo E; Della Zoppa M; Pandolfi L; Cacciatore R; Perotti C; Hoetzenecker K; Jaksch P; Benazzo A; Meloni F
Cells; 2022 Mar; 11(7):. PubMed ID: 35406680
[TBL] [Abstract][Full Text] [Related]
17. Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study.
Di Carlo S; Rossi E; Politano G; Inghilleri S; Morbini P; Calabrese F; Benso A; Savino A; Cova E; Zampieri D; Meloni F
PLoS One; 2016; 11(8):e0161771. PubMed ID: 27564214
[TBL] [Abstract][Full Text] [Related]
18. Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation.
Gao F; Chen J; Wei D; Wu B; Zhou M
Front Med; 2018 Apr; 12(2):224-228. PubMed ID: 28752350
[TBL] [Abstract][Full Text] [Related]
19. Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.
Cebrià I Iranzo MÀ; Vos R; Verleden GM; Gosselink R; Langer D
Arch Bronconeumol (Engl Ed); 2019 May; 55(5):239-245. PubMed ID: 30595421
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.
Kwakkel-van Erp JM; Otten HG; Paantjens AW; van Kessel DA; van Ginkel WG; van den Bosch JM; van de Graaf EA
J Heart Lung Transplant; 2008 Oct; 27(10):1172-5. PubMed ID: 18926413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
